Actinium Pharmaceuticals (ATNM)
(Delayed Data from AMEX)
$7.78 USD
+0.08 (1.04%)
Updated May 1, 2024 04:00 PM ET
After-Market: $7.82 +0.04 (0.51%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.38 | 0.00% |
Earnings Summary
For their last quarter, Actinium Pharmaceuticals (ATNM) reported earnings of -$0.31 per share, beating the Zacks Consensus Estimate of $-0.42 per share. This reflects a positive earnings surprise of 26.19%. Look out for ATNM's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.38 per share, reflecting a year-over-year increase of 34.48%.
Earnings History
Price & Consensus
Zacks News for ATNM
Finch Therapeutics Group, Inc. (FNCH) Reports Q3 Loss, Misses Revenue Estimates
ATNM: What are Zacks experts saying now?
Zacks Private Portfolio Services